Dr. Mark Chassin discusses challenges and growth in performance for quality of care and patient safety with Dr. Nancy Foster, VP of AHA. Dr. Chassin discusses the importance of a balance between transparency for public accountability and the confidentiality of improvement measures, producing consistent excellent care with sustainable practices, and creating organizational cultures that foster committment to zero harm.
top of page
(980) 236-8290
Search
Recent Posts
See AllThe FDA has now finalized the 2024 guidance for 510(k) information required for sterilization of reusable medical devices with some exclusions. (See https://www.fda.gov/media/74445/download?attachment
This article begins to highlight the need for effective contract performance documentation and evaluation. You must place specific, measurable, attainable, relevant, and timely (SMART) key performanc
Post: Blog2_Post
bottom of page